WALTHAM, Mass.--(BUSINESS WIRE)--BG Medicine, Inc. announced today that the results of a controlled study on the utility of its galectin-3 test in heart failure were published in the Journal Clinical Research in Cardiology, a peer-reviewed, international journal that publishes original research and review articles on clinical research studies in the field of cardiology. The article was recently released and is titled, “Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study,” Dirk J. A. Lok, Peter Van Der Meer, Pieta W. Bruggink-André de la Porte, Erik Lipsic, Jan Van Wijngaarden, Hans L. Hillege and Dirk J. van Veldhuisen. DOI: 10.1007/s00392-010-0125-y.
